Key questions about Bioceres Crop Solutions Corp. Ordinary Shares (BIOX)
What is Bioceres Crop Solutions Corp. Ordinary Shares's Market Cap?
Bioceres Crop Solutions Corp. Ordinary Shares's Market Cap is $14.8M, based on as-reported figures from SEC (XBRL) filings.
What is Bioceres Crop Solutions Corp. Ordinary Shares's Enterprise Value?
Bioceres Crop Solutions Corp. Ordinary Shares's Enterprise Value is $128.0M, based on as-reported figures from SEC (XBRL) filings.
What is Bioceres Crop Solutions Corp. Ordinary Shares's Price / Sales?
Bioceres Crop Solutions Corp. Ordinary Shares's Price / Sales is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Bioceres Crop Solutions Corp. Ordinary Shares's EV / Revenue?
Bioceres Crop Solutions Corp. Ordinary Shares's EV / Revenue is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Bioceres Crop Solutions Corp. Ordinary Shares's Revenue (TTM)?
Bioceres Crop Solutions Corp. Ordinary Shares's Revenue (TTM) is $295.1M, based on as-reported figures from SEC (XBRL) filings.
What is Bioceres Crop Solutions Corp. Ordinary Shares's Net Income (TTM)?
Bioceres Crop Solutions Corp. Ordinary Shares's Net Income (TTM) is -$243.2M, based on as-reported figures from SEC (XBRL) filings.
What is Bioceres Crop Solutions Corp. Ordinary Shares's Diluted EPS (TTM)?
Bioceres Crop Solutions Corp. Ordinary Shares's Diluted EPS (TTM) is -3.85, based on as-reported figures from SEC (XBRL) filings.
What is Bioceres Crop Solutions Corp. Ordinary Shares's Net Debt?
Bioceres Crop Solutions Corp. Ordinary Shares's Net Debt is $113.2M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BIOXAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line Item
Jun 30, 2025
Jun 30, 2024
Jun 30, 2023
Jun 30, 2022
Jun 30, 2021
Jun 30, 2020
Jun 30, 2019
Jun 30, 2018
Summary statements of comprehensive income or loss
Revenues from contracts with customers
Initial recognition and changes in the fair value of biological assets at the point of harvest
Cost of sales
Changes in the net realizable value of agricultural products after harvest
Research and development expenses
Selling, general and administrative expenses
Share of profit or loss of joint ventures and associates
Other income or expenses, net
Operating (loss)/ profit
Financial cost
Other financial results
(Loss)/ Profit before income tax
Income tax
(Loss)/ Profit for the year
(Loss) / Profit for the year attributable to:
Equity holders of the parent
Non-controlling interests
(Loss)/ Profit for the year
(Loss)/Profit per share
Basic loss attributable to ordinary equity holders of the parent
Diluted loss attributable to ordinary equity holders of the parent
Other comprehensive (loss)
Items that may be subsequently reclassified to (loss)/ profit
Foreign exchange differences on translation of foreign operations from joint ventures
—
Foreign exchange differences on translation of foreign operations
Items that will not be subsequently reclassified to loss and profit
—
Revaluation of property, plant and equipment, net of tax, of joint ventures and associates 1
—
Revaluation of property, plant and equipment, net of tax 2
—
Total comprehensive (loss)/ profit
Total comprehensive (loss)/ profit attributable to: